Scanning probe and spectroscopy studies of rutile TiO2(110)

In this thesis, surface science techniques were employed to study the chemistry of rutile TiO2(110). Scanning tunnelling microscopy (STM) and ultraviolet photoemission spectroscopy (UPS) have been used to determine the origin of the band-gap state in rutile TiO2(110). By employing electron bombardment to vary the Ob-vac density while monitoring the band-gap state with UPS, we demonstrate that Ob-vac make dominant contribution to the photoemission peak and that is magnitude is directly proportional to the Ob-vac density. CO adsorption on the Pd/TiO2(110) surface was investigated with synchrotron radiation spectroscopies and STM. The Pd islands, which were grown by physical vapour deposition (PVD) of Pd onto the TiO2(110) substrate at ~800 K, had a pseudo-hexagonal shape and were not encapsulated with Ti^n+ (n<4) species from the substrate. In addition, it was found that CO molecules bond vertically and form various ordered overlayers on the Pd(111) islands. O2 adsorption on the cross-linked TiO2(110)-(1x2) surface was investigated with XPS, UPS and STM. The introduction of a small amount of O2 leads to a drastic reduction in the number of the Ti3+ species at the topmost surface layers and the band-gap state intensity, as well as a noticeable rise in the surface workfunction. In STM, O2 and its related molecules were found to preferably adsorb at the centre of the (1x2) strands. Current imaging tunnelling spectroscopy (CITS) was also performed on the same surface at 78 K. It was found that the densities of the two occupied states, one at -0.7 V and and another at -1.3 V, vary between different features on the surface. Moreover, whilst having less-populated occupied states, the cross-links possess an empty state at 1.2 V which cannot be detected anywhere else. This work will be compared with theoretical calculations to elucidate the geometric structure of the cross-link TiO2(110)-(1x2) surface

Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

The clinical validity of drug susceptibility testing (DST) for pyrazinamide, ethambutol, and second-line antituberculosis drugs is uncertain. In an individual patient data meta-analysis of 8955 patients with confirmed multidrug-resistant tuberculosis, DST results for these drugs were associated with treatment outcome

Measurement of the Bs Lifetime in Fully and Partially Reconstructed Bs -> Ds- (phi pi-)X Decays in pbar-p Collisions at sqrt(s) = 1.96 TeV

We present a measurement of the Bs lifetime in fully and partially reconstructed Bs -> Ds(phi pi)X decays in 1.3 fb-1 of pbar-p collisions at sqrt(s) = 1.96 TeV collected by the CDF II detector at the Fermilab Tevatron. We measure tau(Bs) = 1.518 +/- 0.041 (stat.) +/- 0.027 (syst.) ps. The ratio of this result and the world average B0 lifetime yields tau(Bs)/tau(B0) = 0.99 +/-0.03, which is in agreement with recent theoretical predictions.Comment: submitted to Phys. Rev. Let

Observation of the Y(4140)Y(4140) structure in the J/ψ ϕJ/\psi\,\phi Mass Spectrum in B±→J/ψ ϕKB^\pm\to J/\psi\,\phi K cays

The observation of the $Y(4140)$ structure in $B^\pm\rightarrow J/\psi\,\phi K^\pm$ decays produced in $\bar{p} p$ collisions at \sqrt{s}=1.96~\TeV is reported with a statistical significance greater than 5 standard deviations. A fit to the $J/\psi\,\phi$ mass spectrum is performed assuming the presence of a Breit-Wigner resonance. The fit yields a signal of $19^{+6}_{-5}$ resonance events, and resonance mass and width of 4143.4^{+2.9}_{-3.0}(\mathrm{stat})\pm0.6(\mathrm{syst})~\MeVcc and 15.3^{+10.4}_{-6.1}(\mathrm{stat})\pm2.5(\mathrm{syst})~\MeVcc respectively. The parameters of this resonance-like structure are consistent with values reported from an earlier CDF analysis.Comment: 7 pages, 2 figures, submited to Phys. Rev. Let

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Natural Abundance 14C Content of Dibutyl Phthalate (DBP) from Three Marine Algae

Abstract: Analysis of the natural abundance 14C content of dibutyl phthalate (DBP) from two edible brown algae, Undaria pinnatifida and Laminaria japonica, and a green alga, Ulva sp., revealed that the DBP was naturally produced. The natural abundance 14C content of di-(2-ethylhexyl) phthalate (DEHP) obtained from the same algae was about 50-80% of the standard sample and the 14C content of the petrochemical (industrial) products of DBP and DEHP were below the detection limit

Detectivity optimization of ingaas photon emission microscope systems

10.1109/IPFA.2006.251053Proceedings of the International Symposium on the Physical and Failure Analysis of Integrated Circuits, IPFA315-31